{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:45:47Z","timestamp":1793036747664,"version":"4.5.0"},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Follow\u2010up after early medical abortion (EMA) in Australia often entails tracking serum human chorionic gonadotropin levels or performing ultrasonography in\u2010clinic. In other countries, methods of follow\u2010up such as using a low\u2010sensitivity urine pregnancy test (LSUPT), telephone evaluation and a questionnaire have been demonstrated to be safe and acceptable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To evaluate the safety and efficacy of telephone follow\u2010up after EMA using an LSUPT and questionnaire.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>A prospective observational cohort study of patients undergoing telephone follow\u2010up after EMA using an LSUPT and questionnaire was conducted from March 26 to July 31, 2020. Outcomes of patients who returned to clinic because of a positive LSUPT were evaluated and adverse event rates were calculated. Routinely collected adverse event information was used to compare complication rates during the evaluation period with that prior to introduction of the LSUPT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During the study period, 2223 patients underwent the new protocol. One hundred and ninety\u2010seven patients had a positive LSUPT at their telephone follow\u2010up. One hundred and thirty\u2010two had an incomplete abortion, 11 had a continuing pregnancy, 53 had a complete abortion and one left the clinic before full assessment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Introduction of telephone follow\u2010up with an at\u2010home LSUPT reduced the number of patients requiring unnecessary clinic appointments, with over 90% of patients completing their follow\u2010up at home. Complication rates during the study period were found to be at least comparable with previously identified organisational adverse events.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ajo.13731","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T04:18:51Z","timestamp":1689394731000},"page":"797-802","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Telephone <scp>follow\u2010up<\/scp> after early medical abortion using Australia's first low sensitivity urine pregnancy test"],"prefix":"10.1111","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5891-0259","authenticated-orcid":false,"given":"Catriona","family":"Melville","sequence":"first","affiliation":[{"name":"MSI Australia  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Goldstone","sequence":"additional","affiliation":[{"name":"MSI Australia  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7628-9478","authenticated-orcid":false,"given":"Nisreen","family":"Moosa","sequence":"additional","affiliation":[{"name":"MSI Australia  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"e_1_2_5_2_1","volume-title":"The Use of Mifepristone for Medical Abortion","author":"The Royal Australian and New Zealand College of Obstetricians and Gynaecologists","year":"2019"},{"key":"e_1_2_5_3_1","volume-title":"Best practice in abortion care","author":"Royal College of Obstetricians & Gynaecologists","year":"2022"},{"key":"e_1_2_5_4_1","volume-title":"Abortion Care. NICE guideline NG140","author":"National Institute for Health and Care Excellence","year":"2019"},{"key":"e_1_2_5_5_1","volume-title":"Abortion Care Guideline","author":"World Health Organization","year":"2022"},{"key":"e_1_2_5_6_1","volume-title":"Australian Product Information MS 2\u2010Step (Mifepristone and Misoprostol) Tablets","author":"MS Health","year":"2022"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2016.09.007"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.108230"},{"issue":"4","key":"e_1_2_5_9_1","first-page":"590","article-title":"Relationship between blood and urine concentrations of intact human chorionic gonadotropin and its free subunits in early pregnancy","volume":"69","author":"Norman RJ","year":"1987","journal-title":"Obstet Gynecol"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2021.02.004"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016348509156360"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2014.09.009"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.9.2315"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0301\u20102115(03)00012\u20105"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2011.11.010"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2014.01.010"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(14)61054\u20100"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh\u20102017\u2010101868"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179600"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2015.11.013"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2022.02.005"},{"key":"e_1_2_5_22_1","volume-title":"Sigma Company Limited\u2010Clinical Chemistry Hormone IVDs (326739). Therapeutic Goods Administration","author":"Australian Government Department of Health and Aged Care","year":"2019"},{"key":"e_1_2_5_23_1","volume-title":"Search Census Data. Australian Bureau of Statistics","author":"Australian Bureau of Statistics","year":"2021"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.2307\/3097714"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000115511.14004.19"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12608"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133354"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471\u20100528.15922"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2018.03.013"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajo.13731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T07:01:41Z","timestamp":1704610901000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/ajo.13731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1111\/ajo.13731"],"URL":"https:\/\/doi.org\/10.1111\/ajo.13731","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"value":"0004-8666","type":"print"},{"value":"1479-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]},"assertion":[{"value":"2023-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}